Roundtable Discussion: Understanding the Transferable & Unique Considerations for Bioconjugate Development Beyond Oncology
- Understanding potential applications and what has already been achieved in bioconjugate applications beyond oncology
- Outlining similarities in AOC development versus ADCs across DAR and overall conjugate properties
- Breaking down the non-transferable assumptions when developing bioconjugates in rare and chronic indications